1. Home
  2. FHB vs PBLS Comparison

FHB vs PBLS Comparison

Compare FHB & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Hawaiian Inc.

FHB

First Hawaiian Inc.

HOLD

Current Price

$26.14

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

HOLD

Current Price

$26.78

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHB
PBLS
Founded
1858
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
2016
2026

Fundamental Metrics

Financial Performance
Metric
FHB
PBLS
Price
$26.14
$26.78
Analyst Decision
Hold
Strong Buy
Analyst Count
11
5
Target Price
$29.11
★ $41.75
AVG Volume (30 Days)
★ 1.8M
964.3K
Earning Date
10-23-2026
11-17-2026
Dividend Yield
★ 4.11%
N/A
EPS Growth
★ 22.91
N/A
EPS
★ 1.15
N/A
Revenue
★ $880,788,000.00
N/A
Revenue This Year
$7.56
N/A
Revenue Next Year
$53.05
$222.58
P/E Ratio
$22.07
★ N/A
Revenue Growth
★ 8.94
N/A
52 Week Low
$23.26
$22.78
52 Week High
$30.58
$42.49

Technical Indicators

Market Signals
Indicator
FHB
PBLS
Relative Strength Index (RSI) 62.92 42.16
Support Level $25.20 $26.42
Resistance Level $26.18 $41.72
Average True Range (ATR) 0.44 2.39
MACD 0.18 0.18
Stochastic Oscillator 99.26 54.64

Price Performance

Historical Comparison
FHB
PBLS

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: